Cargando…

Co-existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report

BACKGROUND: Pediatric autoinflammatory diseases are rare and still poorly understood conditions resulting from defective genetic control of innate immune system, inter alia from anomalies of NOD2 gene. The product of this gene is Nod2 protein, taking part in maintenance of immune homeostasis. Clinic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dziedzic, Magdalena, Marjańska, Agata, Bąbol-Pokora, Katarzyna, Urbańczyk, Anna, Grześk, Elżbieta, Młynarski, Wojciech, Kołtan, Sylwia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531019/ https://www.ncbi.nlm.nih.gov/pubmed/28750667 http://dx.doi.org/10.1186/s12969-017-0188-7

Ejemplares similares

Activated phosphoinositide 3-kinase delta syndrome 1 and 2 (APDS 1 and APDS 2): similarities and differences based on clinical presentation in two boys
por: Ewertowska, Marlena, et al.
Publicado: (2020)

Germline 3p22.1 microdeletion encompassing RPSA gene is an ultra-rare cause of isolated asplenia
por: Oszer, Aleksandra, et al.
Publicado: (2021)

NOD2 mosaicism in Blau syndrome
por: Mensa-Vilaro, A, et al.
Publicado: (2015)

Extended List of Warning Signs in Qualification to Diagnosis and Treatment of Inborn Errors of Immunity in Children and Young Adults
por: Dąbrowska, Anna, et al.
Publicado: (2023)

Common variable immunodeficiency: different faces of the same disease
por: Grześk, Elżbieta, et al.
Publicado: (2021)

Novel FANCA mutation in the first fully-diagnosed patient with Fanconi anemia in Polish population – case report
por: Repczynska, Anna, et al.
Publicado: (2020)

Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function
por: Mao, Liming, et al.
Publicado: (2022)

Killer-cell immunoglobulin-like receptor genotype and haplotype combinations in children treated for acute lymphoblastic leukemia
por: Kołtan, Sylwia, et al.
Publicado: (2021)

Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients
por: Bąbol-Pokora, Katarzyna, et al.
Publicado: (2021)

Vaccination in children with chronic severe neutropenia – review of recommendations and a practical approach
por: JANCZAR, SZYMON, et al.
Publicado: (2020)

Emperipolesis and cell death in NOD2-related Blau Syndrome and Crohn’s disease
por: Janssen, Carl EI, et al.
Publicado: (2011)

NOD2 Mutation-Associated Case with Blau Syndrome Triggered by BCG Vaccination
por: Arakawa, Akiko, et al.
Publicado: (2021)

Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children’s oncology center
por: Stankiewicz, Joanna, et al.
Publicado: (2023)

PReS-FINAL-2201: A P268S NOD mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome
por: Jain, Lubhani, et al.
Publicado: (2016)

Incomplete penetrance of NOD2 C483W mutation underlining Blau syndrome
por: Chang, Shao-Yu, et al.
Publicado: (2022)

Tofacitinib, a suppressor of NOD2 expression, is a potential treatment for Blau syndrome
por: Ueki, Yoko, et al.
Publicado: (2023)

NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome
por: Xiang, Haotian, et al.
Publicado: (2012)

P03-012 - A P268S NOD2 mutation in one Blau patient
por: Pardeo, M, et al.
Publicado: (2013)

A familial case of Blau syndrome caused by a novel NOD2 genetic mutation
por: Kim, Woojoong, et al.
Publicado: (2016)

Case Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome
por: Jensen, Mary Ellen, et al.
Publicado: (2023)

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
por: Grześk, Elżbieta, et al.
Publicado: (2022)

mTOR Inhibitor Treatment in Patients with Tuberous Sclerosis Complex Is Associated with Specific Changes in microRNA Serum Profile
por: Pawlik, Bartłomiej, et al.
Publicado: (2022)

P808: CONGENITAL NEUTROPENIA PREVALENCE AMONG POLISH CHILDREN – SUMMARY OF A NATIONWIDE GENETIC SCREENING CAMPAIGN
por: Bąbol-Pokora, K., et al.
Publicado: (2022)

Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators
por: Parkhouse, Rhiannon, et al.
Publicado: (2014)

Blau Syndrome-Related CARD15/NOD2 Mutations Are Not Linked to Idiopathic Uveitis in Spanish Patients
por: Rodríguez-Pérez, Noelia, et al.
Publicado: (2009)

An Asymptomatic, Ectopic Mass as a Presentation of Adrenocortical Carcinoma Due to a Novel Germline TP53 p.Phe338Leu Tetramerisation Domain Variant
por: Walenciak, Justyna, et al.
Publicado: (2023)

Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
por: Matsuda, Tomoko, et al.
Publicado: (2022)

Four Decades of Carrier Detection and Prenatal Diagnosis in Hemophilia A: Historical Overview, State of the Art and Future Directions
por: Dardik, Rima, et al.
Publicado: (2023)

Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease
por: Caso, Francesco, et al.
Publicado: (2015)

A Case of Blau Syndrome
por: Chauhan, Krati, et al.
Publicado: (2014)

Mutation in the proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene in a patient with acute lymphoblastic leukemia
por: Gowin, Ewelina, et al.
Publicado: (2021)

Nod2-Nodosome in a Cell-Free System: Implications in Pathogenesis and Drug Discovery for Blau Syndrome and Early-Onset Sarcoidosis
por: Iwasaki, Tomoyuki, et al.
Publicado: (2016)

Sinus of valsalva aneurysm in Blau's syndrome
por: Mourad, Faisal, et al.
Publicado: (2010)

Identification of Blau Syndrome disease signatures
por: Foley, KP, et al.
Publicado: (2011)

A New Mutation in Blau Syndrome
por: Zeybek, Cengiz, et al.
Publicado: (2015)

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia
por: Koltan, Sylwia, et al.
Publicado: (2015)

Aortoarteritis and cardiomyopathy in a child with Blau Syndrome
por: Khubchandani, RP, et al.
Publicado: (2011)

65. Blau syndrome treated with sequential biologics
por: Yi Yong, Cee, et al.
Publicado: (2018)

72. A retrospective diagnosis of Blau syndrome
por: Ellis, Jessica, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_76m11d8ik099jd5oo33sp28lel